Search for: "Medtronic Inc." Results 541 - 560 of 1,086
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2011, 12:54 pm by fraudfighters
  Medtronic Inc., the world’s largest maker of medical devices, has agreed to pay a 23.5 million dollar settlement to the US government to settle a lawsuit alleging that the company violated the False Claims Act. [read post]
12 Dec 2011, 9:03 pm by Ben Vernia
On December 12, the Department of Justice announced that Minnesota-based Medtronic, Inc., had agreed to pay $23.5 million to resolve claims that it used post-market studies of its cardiac devices as a pretext for paying kickbacks to physicians prescribing their use. [read post]
2 Dec 2011, 2:00 pm by Bexis
Medtronic, Inc., 2011 WL 3652311, at *2-3 (N.D. [read post]
29 Nov 2011, 1:09 pm
Medtronic Sofamor Danek, Inc., et. al., 2-07-cv-02175 (TNWD November 23, 2011, Order) (McCalla, J.). [read post]
29 Nov 2011, 12:01 pm by The Docket Navigator
Medtronic Sofamor Danek, Inc., et. al., 2-07-cv-02175 (TNWD November 23, 2011, Order) (McCalla, J.) [read post]
23 Nov 2011, 11:33 am by brettb
Medtronic, Inc., the 510(k) process does not place “requirements” on a device; “substantial equivalence” is not a safety requirement but an exemption from it. [read post]
3 Nov 2011, 3:17 am by Bob Kraft
The AP reports, "Medtronic Inc. says a panel advising the US Food and Drug Administration has concluded that an experimental catheter from the medical device maker poses a potential health risk that outweighs its benefit to patients. [read post]
3 Nov 2011, 3:06 am by Robert Kraft
The AP reports, “Medtronic Inc. says a panel advising the US Food and Drug Administration has concluded that an experimental catheter from the medical device maker poses a potential health risk that outweighs its benefit to patients. [read post]
3 Nov 2011, 3:05 am by Bob Kraft
The AP reports, “Medtronic Inc. says a panel advising the US Food and Drug Administration has concluded that an experimental catheter from the medical device maker poses a potential health risk that outweighs its benefit to patients. [read post]
25 Oct 2011, 7:11 am by Hopkins
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
25 Oct 2011, 7:11 am by Hopkins
Steinbrook notes that conflicts of interest continue as recently reported in The Spine Journal, in connection with a Medtronic clinical trial for recombinant bone morphogenetic protein: “Financial information was available for 12 of the 13 original studies: “the median-known financial associations between the authors and Medtronic Inc were found to be approximately $12,000,000 to $16,000,000 per study (range, $560 000-$23 500 000). [read post]
23 Oct 2011, 5:08 pm
The same process was used to clear the 93,000 artificial hips pulled by J&J last year due to high failure rates, as well as hundreds of external heart defibrillators recalled since 2005 by Minneapolis-based Medtronic Inc. [read post]